Ceribell Inc

CBLL has broken below clearly established support with a bearish Support Failure pattern confirming distribution in a Stage 3 context. The medium-term bias is bearish, and short-term price rejection at the 9/21/50 EMA zone favors immediate sell. We will sell now on the breakdown below the declining EMA cluster, targeting continuation participation. Key risks include potential support at the 200 DMA and any reclaim of EMAs invalidating the bearish posture.

• ↑Q1 2026 revenue rose 29% YoY to $26.5M
• ↑Active hospital accounts grew to 680, just 3% penetrated
• ↓Q1 net loss expanded to $19.7M, deepening annual deficits